United States · FDA National Drug Code directory
Senexon-S
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0615-8331_ed210a7f-6612-4caf-851f-c04b02d0cf52
- Product NDC
- 0615-8331
- Form
- TABLET, FILM COATED
- Composition / generic term
- Docusate Sodium 50mg and Sennosides 8.6mg
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20191002
- Source listing expiry
- 20261231
Source-listed ingredients
- SENNOSIDES — 8.6 mg/1
- DOCUSATE SODIUM — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-05) · 0615-8331-05
- 28 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-28) · 0615-8331-28
- 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-39) · 0615-8331-39
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →